tiprankstipranks
Pieris Pharmaceuticals (DE:PI60)
FRANKFURT:PI60

Pieris Pharmaceuticals (PI60) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
1Neutral
12Bearish
Technical Analysis Consensus
Buy
4Bullish
1Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Pieris Pharmaceuticals’s (PI60) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Pieris Pharmaceuticals is a Sell.
Pieris Pharmaceuticals’s (PI60) 20-Day exponential moving average is 10.07, while Pieris Pharmaceuticals’s (PI60) share price is €10.064, making it a Sell.
Pieris Pharmaceuticals’s (PI60) 50-Day exponential moving average is 10.24, while Pieris Pharmaceuticals’s (PI60) share price is €10.064, making it a Sell.

Pieris Pharmaceuticals (PI60) Pivot Points

Jul 23, 2024, 04:24 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
8.08
9.07
9.57
10.56
11.06
12.05
12.54
Fibonacci
9.07
9.64
9.99
10.56
11.13
11.48
12.05
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pieris Pharmaceuticals (PI60) Moving Averages

Jul 23, 2024, 04:24 AM
Period
Simple
Exponential
MA5
10.06Sell
10.06Sell
MA10
10.06Buy
10.06Sell
MA20
10.06Sell
10.07Sell
MA50
10.06Buy
10.24Sell
MA100
10.94Sell
10.91Sell
MA200
12.68Sell
12.85Sell
Pieris Pharmaceuticals’s (PI60) 10-Day exponential moving average is 10.06, while Pieris Pharmaceuticals’s (PI60) share price is €10.064, making it a Sell.
Pieris Pharmaceuticals’s (PI60) 100-Day exponential moving average is 10.91, while Pieris Pharmaceuticals’s (PI60) share price is €10.064, making it a Sell.
Pieris Pharmaceuticals’s (PI60) stock price is €10.064 and Pieris Pharmaceuticals’s (PI60) 50-day simple moving average is 10.06, creating a Buy signal.
Pieris Pharmaceuticals’s (PI60) stock price is €10.064 and Pieris Pharmaceuticals’s (PI60) 100-day simple moving average is 10.94, creating a Sell signal.
Pieris Pharmaceuticals’s (PI60) stock price is €10.064 and Pieris Pharmaceuticals’s (PI60) 200-day simple moving average is 12.68, creating a Sell signal.

Pieris Pharmaceuticals (PI60) Technical Indicators

Jul 23, 2024, 04:24 AM
Name
Value
Implied Action
RSI (14)
33.34
Neutral
STOCH (9,6)
<0.01
Buy
STOCHRSI (14)
<0.01
Buy
MACD (12,26)
-0.02
Sell
Williams %R
-100.00
Buy
CCI (14)
0.00
-
ATR (14)
1.48
-
Ultimate Oscillator
>-0.01
Sell
ROC
0.00
-
Bull/Bear Power (13)
1.49
Buy
Pieris Pharmaceuticals’s (PI60) Relative Strength Index (RSI) is 33.34, creating a Neutral signal.

FAQ

Is PI60 a Buy, Hold, or Sell?
Based on PI60’s technical indicators, PI60 is a Sell.
    What is PI60’s RSI (14)?
    PI60’s RSI (14) is 33.34, which suggests PI60 is a Neutral.
      What is PI60’s MACD?
      PI60’s MACD is -0.02, which suggests PI60 is a Sell.
        What is PI60’s 5-day moving average?
        PI60’s 5-day moving average is 10.06, which suggests PI60 is a Sell.
          What is PI60’s 20-day moving average?
          PI60 20-day moving average is 10.06, which suggests PI60 is a Sell.
            What is PI60’s 50-day moving average?
            PI60’s 50-day moving average is 10.06, which suggests PI60 is a Buy.
              What is PI60’s 200-day moving average?
              PI60’s 200-day moving average is 12.68, which suggests PI60 is a Sell.
                What is PI60’s Williams % R (14)?
                PI60’s Williams % R (14) is -100.00, which suggests PI60 is a Buy.
                  What is PI60’s CCI (14)?
                  Currently, no data Available
                  What is the share price of Pieris Pharmaceuticals?
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis